Issue Brief CAP’s drug pricing framework would empower Medicare and private payers to negotiate effectively for drug prices, backed by binding arbitration.
Zeke Emanuel and Topher Spiro discuss if the Affordable Care Act’s insurance exchanges are sustainable.
Topher Spiro discusses why the U.S. Department of Justice's most recent action comes at a critical moment for the health care system and antitrust policy.
Issue Brief PCORI has made some progress but needs to act quickly to make a bigger impact on comparative effectiveness research.
Issue Brief More than 2 million pregnant women will be potentially at risk from Zika this summer and fall.
Report States should take the lead in implementing innovative cost control and quality improvement reforms.
Topher Spiro and Lanhee Chen discuss the bipartisan benefits of investing in nurse coaching programs.
Issue Brief Experiences from past mergers show that divestitures most likely will not be a successful remedy in the proposed Aetna-Humana merger.
Topher Spiro and Meghan O'Toole describe how home-visiting programs can improve the lives of families in Pennsylvania and save millions of dollars for the state.
Report Creating a new Medicaid benefit for evidence-based home visiting services would simplify funding and allow states and communities to scale services, improve outcomes for families, and produce significant savings for states and the federal government.
Author Topher Spiro argues that drugs should be priced based on their effectiveness.
Report Sustainable drug pricing requires paying for drugs based on their benefits to patients.
Report Medicare’s Pioneer ACO Model has shown modest yet improving results so far. The Centers for Medicare & Medicaid Services should make improvements to the Pioneer ACO Model while also expanding bundled payment reforms.